BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting

Bezisterim appears to possess broad homeostatic properties relevant to inflammation and human disorders related to aging

Patients treated with bezisterim experienced 2 to 4 years age deceleration advantage
compared to placebo